Dr. Peña’s clinical and research interests’ include the treatment for Barrett’s esophagus and early esophageal cancer using endoscopic mucosal resection (EMR) and mucosal ablation including radiofrequency ablation and cryoablation; endoscopic retrograde cholangiopancreatography (ERCP) for biliary and pancreatic disorders including cancer, esophageal stenting and wireless capsule endoscopy for small bowel evaluation. Additional research interests include endoscopic outcomes and capsule endoscopy.
Saller J, Jiang K, Xiong Y, Yoder SJ, Neill K, Pimiento JM, Pena L, Corbett FS, Magliocco A, Coppola D. A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer. Digest Dis Sci. 2021 Mar. Pubmedid: 33713247.
Afiat TN, Hembree TN, Dean EA, Araujo C, Pena LR, Rosa M, Han HS, Hendrix K, Ramsakal A. Diffuse Intrasinusoidal Hepatic Metastasis from Breast Cancer Presenting as Liver Failure: Effective and Rapid Treatment with Weekly Low-Dose Adriamycin. Am J Case Rep. 2020 Sep.21:e924141. Pubmedid: 32877389. Pmcid: PMC7491943.
Song E, Segarra D, Latifi K, Leuthold S, Belinc D, Pena L, Malafa M, Frakes JM, Hoffe SE. Recognition of Tumor Invasion of a Pancreatic Head Biliary Stent During Stereotactic Body Radiation Therapy. Pract Radiat Oncol. 2019 May.9(3):132-135. Pubmedid: 30708132.
Lopez C, Abuel-Haija M, Pena L, Coppola D. Novel Germline Mutation Associated with Cowden Syndrome and Osteosarcoma. Cancer Genomics Proteomics. 2018 Mar.15(2):115-120. Pubmedid: 29496690. Pmcid: PMC5892603.
Setia N, Lauwers GY, Peña LR. Unearthing the significance of buried intestinal metaplasia. Gastrointest Endosc. 2018 01.87(1):75-76. Pubmedid: 29241864.
Saligram S, Lim D, Pena L, Friedman M, Harris C, Klapman J. Safety and feasibility of esophageal self- expandable metal stent placement without the aid of fluoroscopy. Dis Esophagus. 2017 Aug.30(8):1-6. Pubmedid: 28575246.
Davis-Yadley AH, Neill KG, Malafa MP, Pena LR. Advances in the Endoscopic Diagnosis of Barrett Esophagus. Cancer Control. 2016 Jan.23(1):67-77. Pubmedid: 27009460.
Sundar Alagusundaramoorthy S, Vilchez V, Zanni A, Sourianarayanane A, Maynard E, Shah M, Daily MF, Pena LR, Gedaly R. Role of transplantation in the treatment of benign solid tumors of the liver: a review of the United Network of Organ Sharing data set. JAMA Surg. 2015 Apr.150(4):337-342. Pubmedid: 25714928.
Horn TL, Reynolds J, de Villiers W, Peña LR. Hepatitis C virus and inflammatory bowel disease. Digest Dis Sci. 2009 Jun.54(6):1171-1177. Pubmedid: 18975088.
Pena LR, Cox T, Koch AG, Bosch A. Study comparing oesophageal capsule endoscopy versus EGD in the detection of varices. Dig Liver Dis. 2008 Mar.40(3):216-223. Pubmedid: 18082473.
Knopp TC, Mardini HE, Peña LR. Wireless capsule endoscopy indication as a predictor of study quality. Digest Dis Sci. 2008 Jul.53(7):1898-1901. Pubmedid: 18034326.
Peña LR, Mardini H, Nickl N. An instrument to predict endoscopy tolerance: a prospective randomized study. Digest Dis Sci. 2007 Oct.52(10):2888-2891. Pubmedid: 17394063.
Sifford M, Koch A, Lee E, Peña LR. Abnormal liver tests as an initial presentation of celiac disease. Digest Dis Sci. 2007 Nov.52(11):3016-3018. Pubmedid: 17530403.
Bosch A, Peña LR. The sphincter of oddi. Digest Dis Sci. 2007 May.52(5):1211-1218. Pubmedid: 17356921.
Peña LR, Mardini HE, Nickl NJ. Development of an instrument to assess and predict satisfaction and poor tolerance among patients undergoing endoscopic procedures. Digest Dis Sci. 2005 Oct.50(10):1860-1871. Pubmedid: 16187188.
Horn TL, Peña LR. Subcapsular hepatic hematoma after ERCP: case report and review. Gastrointest Endosc. 2004 Apr.59(4):594-596. Pubmedid: 15044910.
Peña LR, Nand S, De Maria N, Van Thiel DH. Hepatitis C virus infection and lymphoproliferative disorders. Digest Dis Sci. 2000 Sep.45(9):1854-1860. Pubmedid: 11052331.
Marsano LS, Peña LR. The interaction of alcoholic liver disease and hepatitis C. Hepatogastroenterology. 1998 Mar.45(20):331-339. Pubmedid: 9638402.
Shiani A, Narayanan S, Pena L, Friedman M. The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer. Cancer Control. 24(3):1073274817729240. Pubmedid: 28975833. Pmcid: PMC5937237.
The Provider Rating is an average of all responses to specific care provider-related
questions from our nationally-recognized
Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive
different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our
Patient Satisfaction Survey . The comments are submitted by patients
and reflect their views and opinions. Patients are de-identified for confidentiality and
We post both positive and negative comments from the surveys. We do not post comments
that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may
risk the privacy of our patients.
A “[…]” in the comments below indicates de-identified patient information or comments that
are unrelated to the patient’s experience with the visit to the provider, such as
comments related to another provider, about the survey itself, or otherwise completely
Not all providers will have a star rating or comments. In order to ensure accuracy of our
ratings, we only display ratings for providers who have a minimum of 30 completed from
the previous 12 months.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey
Patient Satisfaction Survey. If a provider does not have ratings or comments listed it
can be for several reasons, including:
The provider has not yet received the minimum number of patient satisfaction surveys
to be eligible for display. We require a minimum of 30 surveys before we post
results to ensure that the rating is statistically reliable and a true reflection of
He or she may be a researcher or other type of provider that does not see patients.
The provider practices in a specialty or office that does not use the specified
surveys currently used for these ratings.
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate buttonbelow. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub